---
document_datetime: 2023-09-21 18:27:58
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/quintanrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: quintanrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.3597308
conversion_datetime: 2025-12-21 17:14:04.337273
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MAJOR CHANGES 1

| No      | Scope                                                                                                                                                                                                                                                                                                                                                                         | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0008 | Product Update of Summary of Product Characteristics and Package Leaflet Update of sections 4.4 and 4.8 of the SPC and PL to implement the class labelling text on the risk of apnoea following vaccination of very prematurely born infants agreed by the CHMP in July 2007. In addition the MAH took the opportunity to update the list of local representatives in the PL. | 15/11/2007          | 11/12/2007                               | no SPC, PL                       | longer Following a review on the risk of apnoea in very premature infants after immunisation the CHMP recommended a class labelling on apnoea for all vaccines in very premature infants. The SPC was updated to include information about the potential risk of apnoea and the need for respiratory monitoring for 48-72h, when the primary immunisation series is administered to very premature infants (born < 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity. Nonetheless, preterm infants should not be withdrawn from the immunisation scheme because the benefit of vaccination outweighs the risk of apnoea. |
| II/0005 | Change(s) to the test method(s) and/or specifications for the active substance Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                 | 15/09/2005          | 03/10/2005                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0004 | Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                                                                                                | 23/06/2005          | 30/06/2005                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0003 | Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                                                                                                | 23/06/2005          | 30/06/2005                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0002 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                               | 23/06/2005          | 30/06/2005                               |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

## Quintanrix

Medicinal Product no longer authorised Procedural steps taken and scientific information after the authorisation

1 Major changes e.g. Type II variations, Annex II applications, Renewals and Annual Reassessments

2 SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet)

<!-- image -->

<div style=\"page-break-after: always\"></div>

## MINOR CHANGES 3

| No      | Scope                                                                                           | Product Information affected 2   | Date 4     |
|---------|-------------------------------------------------------------------------------------------------|----------------------------------|------------|
| IB/0007 | 37_b_Change in the specification of the finished product - add. of new test parameter           |                                  | 28/09/2005 |
| IA/0006 | 28_Change in any part of primary packaging material not in contact with finished product        |                                  | 27/06/2005 |
| IB/0001 | 38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient |                                  | 13/05/2005 |

## Medicinal Product no longer authorised Scope 37\\_b\\_Change in the specification of the finished product - add. of new test parameter 28\\_Change in any part of primary packaging material not in contact with finished product 38\\_b\\_Change in test procedure of finished product - minor change, biol. active subst./excipient

3 Minor changes e.g. Type I variations and Notifications

4 Date of entry into force of the change